Address: 3-1-24 Matsuyama, Kiyose-shi, Tokyo 204-8533 Japan
The Department of Pathophysiology and Host Defense comprises divisions of Pathophysiology, Immunology, Animal Experiment and Senior Researcher section. In the Divisions of Pathophysiology and Immunology, we aim to analyse infection, development, and recurrence of tuberculosis and other mycobacterial diseases at molecular levels. We also try to elucidate their pathophysiological mechanisms.
The Division of Animal Experiment supports basic research using experimental animals. The Senior Researcher section is responsible for projects on novel anti-mycobacterial drugs and combinational chemotherapy and implementation of pharmacological studies.
We have been conducting collaborative researches with Vietnamese institutes through NCGM-BMH Medical Collaboration Center for more than 10 years. Our research projects include host immunogenetics; host-pathogen interactions; and clinical epidemiology on mycobacterial infection, development, and recurrence of the disease. Particularly, control of multi-drug resistant tuberculosis is an important target.
We have been investigating the functional significance of airway defense genes and their polymorphisms. We have so far identified novel mucin genes on the human sixth chromosome and characterization of these genes is underway. Our target genes include beta-defensins and interferon-inducible anti-viral genes as well. This would help us to understand pathogenesis of airway infectious/inflammatory diseases widely.
M. tuberculosis is an intracellular bacterium, which can proliferate within phagocytosed macrophages. M. tuberculosis gains this ability by escaping from the killing and digesting mechanisms of macrophages. We have been studying the unique strategy of its intracellular parasitism by investigating the membrane trafficking in infected macrophages.
We have been studying new drug development for intractable opportunistic non-tuberculous mycobacteriosis (NTM) disease caused mainly by Mycobacterium avium-intracellulare complex (MAC). In our project, the screened candidate compounds are now in progress at the final step of the preclinical stage. Moreover, we have established Drug-PK-Analysis System by LC-MS/MS Device: Totally 32 drugs, approved anti-TB drugs, and novel candidates are available. In combination with LC-MS/MS Drug PK Analysis System and High Throughput in vivo Evaluation System by the Molecular Imaging Device, we are now investigating the next generation drug-combination regimen to create the future short course TB chemotherapy 3-4 months.
Noguchi S, Hamano E, Matsushita I, Hijikata M, Ito H, Nagase T, Keicho N. Differential effects of a common splice site polymorphism on the generation of OAS1 variants in human bronchial epithelial cells. Hum Immunol 74 (3): 395-401, 2013.
Noguchi S, Hijikata M, Hamano E, Matsushita I, Ito H, Ohashi J, Nagase T, Keicho N. MxA transcripts with distinct first exons and modulation of gene expression levels by single-nucleotide polymorphisms in human bronchial epithelial cells. Immunogenetics 65 (2): 107-14, 2013.
Pitabut N, Sakurada S, Tanaka T, Ridruechai C, Tanuma J, Aoki T, Kantipong P, Piyaworawong S, Kobayashi N, Dhepakson P, Yanai H, Yamada N, Oka S, Okada M, Khusmith S, Keicho N. Potential function of granulysin, other related effector molecules and lymphocyte subsets in patients with TB and HIV/TB coinfection. Int J Med Sci 10 (8): 1003-1014, 2013.
Hang NT, Maeda S, Lien LT, Thuong PH, Hung NV, Thuy TB, Nanri A, Mizoue T, Hoang NP, Cuong VC, Ngoc KT, Sakurada S, Endo H, Keicho N. Primary drug-resistant tuberculosis in Hanoi, Viet Nam: present status and risk factors. PLoS One 8 (8): e71867, 2013.
Hung NV, Ando H, Thuy TT, Kuwahara T, Hang NT, Sakurada S, Thuong PH, Lien LT, Keicho N. Clonal expansion of Mycobacterium tuberculosis isolates and coexisting drug resistance in patients newly diagnosed with pulmonary tuberculosis in Hanoi, Vietnam. BMC Res Notes 6:444,2013.
Hang NT, Matsushita I, Shimbo T, Hong LT, Tam DB, Lien LT, Thuong PH, Cuong VC, Hijikata M, Kobayashi N, Sakurada S, Higuchi K, Harada N, Endo H, Keicho N. Association between tuberculosis recurrence and interferon-γ response during treatment. J Infect 69:616-626, 2014.
Hijikata M, Matsushita I, Hang NT, Maeda S, Thuong PH, Tam DB, Shimbo T, Sakurada S, Cuong VC, Lien LT, Keicho N. Age-dependent association of mannose-binding lectin polymorphisms with the development of pulmonary tuberculosis in Viet Nam. Hum Immunol 75:840-846, 2014.
Maeda S, Hang NT, Lien LT, Thuong PH, Hung NV, Hoang NP, Cuong VC, Hijikata M, Sakurada S, Keicho N. Mycobacterium tuberculosis strains spreading in Hanoi, Vietnam: Beijing sublineages, genotypes, drug susceptibility patterns, and host factors. Tuberculosis 94:649-656, 2014.
Hang NT, Maeda S, Keicho N, Thuong PH, Endo H. Sublineages of Mycobacterium tuberculosis Beijing genotype strains and unfavorable outcomes of anti-tuberculosis treatment. Tuberculosis (Edinb). 95:336-342, 2015.
Jeong S, Patel N, Edlund CK, Hartiala J, Hazelett DJ, Itakura T, Wu PC, Avery RL, Davis JL, Flynn HW, Lalwani G, Puliafito CA, Wafapoor H, Hijikata M, Keicho N, Gao X, Argüeso P, Allayee H, Coetzee GA, Pletcher MT, Conti DV, Schwartz SG, Eaton AM, Fini ME. Identification of a Novel Mucin Gene HCG22 Associated With Steroid-Induced Ocular Hypertension. Invest Ophthalmol Vis Sci. 56:2737-2748, 2015.
Matsushita I, Hang NT, Hong LT, Tam DB, Lien LT, Thuong PH, Cuong VC, Hijikata M, Kobayashi N, Sakurada S, Higuchi K, Harada N, Keicho N. Dynamics of immune parameters during the treatment of active tuberculosis showing negative interferon-gamma response at the time of diagnosis. Int J Infect Dis 40:39-44,2015.
Yatagai Y, Hirota T, Sakamoto T, Yamada H, Masuko H, Kaneko Y, Iijima H, Naito T, Noguchi E, Tamari M, Kubo M, Takahashi A, Konno S, Makita H, Nishimura M, Hijikata M, Keicho N, Homma S, Taguchi Y, Azuma A, Kudoh S, Hizawa N. Variants nearby the HLA complex group 22 gene confer increased susceptibility to late-onset asthma in Japanese populations. J Allergy Clin Immunol 138:281-283.e13, 2016.
Nakauchi A, Wong JH, Mahasirimongkol S, Yanai H, Yuliwulandari R, Mabuchi A, Liu X, Mushiroda T, Wattanapokayakit S, Miyagawa T, Keicho N, Tokunaga K. Identification of ITPA as a susceptibility gene to young-onset Tuberculosis on Chromosome 20. Human Genome Variation 3:15067, 2016.
Hijikata M, Matsushita I, Hang NT, Thuong PH, Tam DB, Maeda S, Sakurada S, Cuong VC, Lien LT, Keicho N. Influence of the polymorphism of the DUSP14 gene on the expression of immune-related genes and development of pulmonary tuberculosis. Genes and Immunity 17:207-212, 2016.
Thuong PH, Tam DB, Sakurada S, Hang NT, Hijikata M, Hong LT, Ngoc PT, Anh PT, Cuong VC, Matsushita I, Lien LT and Keicho N. Circulating granulysin levels in healthcare workers and latent tuberculosis infection estimated using interferon-gamma release assays. BMC Infectious Diseases, 16:580, 2016.
Horita Y, Doi N. Comparative study of the effects of antituberculosis drugs and antiretroviral drugs on cytochrome P450 3A4 and P-glycoprotein．Antimicrob Agents Chemother． 58:3168-3176, 2014.
Horita Y, Maeda S, Kazumi Y, Doi N. In vitro susceptibility of Mycobacterium tuberculosis isolates to an oral carbapenem alone or in combination with β-lactamase inhibitors．Antimicrob Agents Chemother． 58:7010-7014, 2014.